Magnevist® Injection Enhanced MRA Compared to Non Contrast MRA for the Detection of Structural Abnormalities of the Aortic Arch and Cerebral Branches

NCT00310609 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

123

Enrollment

INDUSTRY

Sponsor class

Conditions

Cardiovascular Abnormalities

Interventions

DRUG: Gadopentetate dimeglumine (Magnevist)

Sponsor

Bayer